FSSAI initiates legal action against Nestle India over infant nutrition products
The Food Safety and Standards Authority of India (FSSAI) has initiated legal action against Nestle India for alleged non-compliance with infant nutrition regulations. The regulator cited misleading promotional claims and sub-standard biotin content in specific infant formula products.
Why it matters
This action highlights the strict regulatory oversight of infant nutrition products in India and the potential legal and financial risks for multinational food corporations.
The Food Safety and Standards Authority of India (FSSAI) on Friday said it has initiated legal action against Nestle India Ltd for alleged non-compliance with food safety norms in three infant nutrition products.
According to FSSAI, it examined NAN Excella Pro Stage 1, Lactogen Pro 1, and a follow-up formula along with their promotional material available on e-commerce platforms.
In NAN Excella Pro Stage 1, the regulator flagged claims relating to "5HMOs" and "Whey Protein," while in Lactogen Pro 1, it observed a claim describing "Whey Protein" as easy to digest, the regulator said in a social media post.
FSSAI said it had sought clarifications from Nestle India on these claims.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in